Pharmacology Final Exam Overview

Aug 8, 2024

Pharmacology Final Exam Review

Exam Breakdown

  • One-third of the exam covers material after Exam 2.
  • Two-thirds of the exam covers material from Exams 1 and 2.

Muscle Relaxants

Central Acting Skeletal Muscle Relaxants

  • Key Medications: Baclofen, Cyclobenzaprine, Carisoprodol, Diazepam
  • Baclofen:
    • Increases potassium permeability β†’ decreased muscle contraction
    • Indications: Multiple sclerosis, muscle rigidity, spinal cord injuries
    • Adverse Effects: CNS depression, dizziness, constipation, hypotension, urinary retention
    • Nursing Considerations: Do not stop abruptly, start at low dose, take on empty stomach
  • Diazepam: Used for anxiety and as a muscle relaxant
    • Indications: Anxiety, muscle relaxation
    • Adverse Effects: Drowsiness, potential rebound effect if stopped abruptly

Direct Acting Skeletal Muscle Relaxants

  • Key Medications: Dantrolene, Botulinum toxin (Botox)
  • Dantrolene: Indicated for malignant hyperthermia
    • Adverse Effects: Muscle weakness, drowsiness, dizziness, hepatotoxicity
    • Indications: Muscle spasms in multiple sclerosis, cerebral palsy, malignant hyperthermia

General and Local Anesthetic Agents

General Anesthesia

  • Balanced Anesthesia: Use of multiple drugs to prevent toxicity and adverse effects
  • Medications: Barbiturates, Non-barbiturates, Nitrous oxide, Volatile agents
  • Stages of General Anesthesia: Induction (loss of pain sensation), Combative excitement (danger period), Maintenance (relaxation, loss of reflexes)
  • Phases of General Anesthesia: Induction (Stage 1 & 2), Maintenance (Stage 3), Recovery (post-Stage 3)

Local Anesthesia

  • Lidocaine: Local anesthetic and anti-arrhythmic
    • Indications: Infiltration anesthesia, nerve blocks
    • Adverse Effects: Local reactions, hypotension, incontinence, paresthesia, seizures

Neuromuscular Junction Blocking Agents

Depolarizing Agents

  • Succinylcholine: Paralyzes patient for intubation
    • Adverse Effects: Hyperkalemia, muscle pain, malignant hyperthermia
    • Malignant Hyperthermia Treatment: Dantrolene
    • Nursing Interventions: Monitor vital signs, initiate cooling measures, administer 100% O2, administer dantrolene

Non-Depolarizing Agents

  • Medications: Pancuronium, Atracurium, Cisatracurium
  • Indications: Muscle relaxation during surgery, mechanical ventilation

Upper Respiratory Tract Medications

  • Antitussives: Dextromethorphan (Robitussin)
    • Indications: Nonproductive cough
    • Adverse Effects: Drowsiness, dry mucous membranes
    • Drug Interactions: MAOIs
  • Topical Nasal Decongestants: Oxymetazoline (Afrin)
    • Adverse Effects: Rebound congestion, mucosal ulcerations
    • Nursing Interventions: Do not use for more than 5-7 days
  • Oral Decongestants: Pseudoephedrine, Phenylephrine
  • First-Generation Antihistamines: Diphenhydramine (Benadryl)
    • Adverse Effects: Drowsiness, anticholinergic effects
    • Pediatric Considerations: Test at home before travel
  • Second-Generation Antihistamines: Loratadine (Claritin)
    • Adverse Effects: Fewer compared to first-generation
    • Indications: Patients who need to remain alert
  • Expectorants: Guaifenesin (Mucinex)
    • Indications: Coughing up secretions
  • Mucolytics: Acetylcysteine
    • Indications: Thick secretions, acetaminophen overdose, acute renal failure

Lower Respiratory Tract Medications

Pathophysiology

  • Asthma: Bronchoconstriction
  • COPD: Chronic bronchitis (mucus production), Emphysema (air space enlargement)
  • ARDS: Acute lung injury, alveolar capillary membrane damage

Medications

  • Epinephrine: Beta 1 and 2 agonist, rescue inhaler
  • Albuterol: Beta 2 agonist, rescue inhaler
    • Adverse Effects: Cardiac arrhythmias, increased heart rate, increased blood pressure
  • Anticholinergics: Ipratropium (Atrovent)
    • Adverse Effects: Dry mouth, urinary retention
  • Inhaled Glucocorticoids: Budesonide
    • Nursing Interventions: Administer after albuterol, rinse mouth after use
  • Leukotriene Receptor Antagonists: Montelukast (Singulair)
    • Adverse Effects: Multiple drug interactions

Review from Exams 1 and 2

Anti-Inflammatories

  • Adverse Effects: GI bleeding, liver function monitoring (ALT/AST)
  • Acetaminophen: Hypothalamus action for fever reduction, hepatotoxicity
  • Ibuprofen: First-line for rheumatoid arthritis
  • Auranofin: Second-line for rheumatoid arthritis
    • Adverse Effects: Bone marrow suppression, renal toxicity, GI effects, rhabdomyolysis

Opioids and Narcotics

  • Adverse Effects: Respiratory depression, urinary retention
  • Antidote for overdose: Naloxone (Narcan)
  • Morphine: Primary narcotic agonist
  • Sumatriptan: Preferred for migraines over ergotamines

Antivirals

  • Medications: Oseltamivir (Tamiflu) for influenza, Remdesivir for COVID-19
  • CD4 Count: Higher count indicates effective treatment

Antifungals

  • Considerations: Avoid alcohol, monitor ALT/AST

Antihypertensives

  • ACE Inhibitors: Prevent conversion of angiotensin I to II
    • Adverse Effects: Angioedema, dry cough, hyperkalemia
  • ARBs: Block angiotensin II receptors
  • Beta Blockers: Selective (beta-1) and non-selective
  • Calcium Channel Blockers: Dihydropyridines (vascular) and non-dihydropyridines (heart rate)

Heart Failure

  • Digoxin: Monitor for toxicity (yellow halos), antidote is Digibind
  • Anticoagulants: Heparin (PTT), Warfarin (INR), Rivaroxaban
    • Antidotes: Protamine sulfate for heparin, Vitamin K for warfarin

Diuretics

  • Loop Diuretics: Furosemide (Lasix), potassium-wasting
    • Adverse Effects: Hypokalemia
  • Potassium-Sparing: Spironolactone
    • Adverse Effects: Hyperkalemia
  • Thiazide-Like: Hydrochlorothiazide
    • Adverse Effects: Hyperuricemia, elevated blood sugar
  • Osmotic: Mannitol
  • Carbonic Anhydrase Inhibitors: Used for glaucoma

Anemia

  • Iron Supplementation: Ferrous sulfate via straw to prevent staining
    • Adverse Effects: GI upset, dark stools
    • Antidote for overdose: Deferoxamine
  • Folic Acid and Vitamin B12: Used for megaloblastic anemia
  • Epoetin Alpha: Stimulates RBC production

General Concepts

  • Five Rights of Medication: Right dose, time, patient, route, drug
  • Pharmacokinetics: Absorption, distribution, metabolism, excretion
  • Half-Life: Time for drug concentration to halve
  • Lab Values: Glucose (70-110), A1C (>6.5% indicates diabetes), Potassium (3.5-5), Creatinine (>1.3 indicates kidney damage), WBC (5-10 or 4-11), ALT/AST (indicative of liver disease), CD4 count (500-1200), TSH (high in hypothyroidism, low in hyperthyroidism)

Final Tips

  • Review study guide thoroughly.
  • Practice teaching the material.
  • Take practice tests.
  • Good luck on the final exam!